Artificial intelligence in pediatric intensive care units: current applications in sepsis management

Sheng Fu1,2, Fei Li3, Su-Yun Qian4

  • 1Department of Pediatrics, KK Women's and Children's Hospital, Singapore, Singapore.

Insights

Artificial intelligence (AI) shows promise for early sepsis detection in pediatric intensive care units (PICUs). While AI models outperform traditional methods, challenges remain in implementation and ensuring equitable access to these advanced clinical decision support systems.

Area of Science:

  • Pediatric critical care medicine
  • Artificial intelligence in healthcare
  • Sepsis management

Background:

  • Early sepsis detection in pediatric intensive care units (PICUs) is crucial but difficult due to nonspecific symptoms and physiological variability.
  • Artificial intelligence (AI) presents potential for precision sepsis management, yet faces methodological and implementation hurdles for clinical use.

Purpose of the Study:

  • To systematically review the application of AI in sepsis management within PICUs.
  • To evaluate AI's effectiveness in prediction, risk stratification, and clinical decision support for pediatric sepsis.

Main Methods:

  • Conducted a systematic review of original research, meta-analyses, reviews, guidelines, and consensus statements.
  • Searched major databases (PubMed, Embase, Cochrane, etc.) up to March 2026 using terms related to AI, machine learning, deep learning, pediatric sepsis, and clinical decision support systems.
  • Included studies focused on sepsis management in pediatric and neonatal intensive care settings.

Main Results:

  • AI models demonstrated superior performance over traditional scoring systems for early prediction and risk stratification of pediatric sepsis.
  • Long short-term memory networks were effective for temporal patterns, while random forests were robust for discrete data.
  • AI-driven clinical decision support systems improved adherence to sepsis bundles, but false-positive rates highlighted infrastructure disparities.
  • Multi-omics integration revealed distinct biological endotypes for personalized therapy, with economic evaluations suggesting cost reduction and optimized resource allocation.
  • Recent policies emphasize pediatric-specific validation and algorithmic fairness for AI deployment.

Conclusions:

  • AI offers technical advantages in pediatric sepsis management, but clinical utility depends on explainable AI and bridging infrastructure gaps.
  • Robust quality controls and policy frameworks are essential to integrate AI as a reliable diagnostic adjunct in standard pediatric care.
  • Addressing transparency and systemic disparities is key for equitable AI implementation in PICUs.
Abstract